A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014; Jul 20 [Epub ahead of print])

Psychopharmacology

Volumn 231, Issue 19, 2014, Pages 3907-3908

  McGirr, Alexander ^a   Berlim, Marcelo T ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT;

BIPOLAR DEPRESSION; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; EVIDENCE BASED PRACTICE; HUMAN; LETTER; MAJOR DEPRESSION; META ANALYSIS (TOPIC); METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SCORING SYSTEM; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW (TOPIC); BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT;

ANESTHETICS, DISSOCIATIVE; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; KETAMINE;

EID: 84919882503     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3731-y     Document Type: Letter

References (10)

1. Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S et al (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67(8):793-802
2. Fond G, Loundou A, Rabu C, Macgregor A, Lancon C, Brittner M et al (2014) Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology 20:20
3. Ghasemi M, Kazemi MH, Yoosefi A, Ghasemi A, Paragomi P, Amini H, et al (2013) Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder. Psychiatry Res 215(2):355-361
4. Kudoh A, Takahira Y, Katagai H, Takazawa T (2002) Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 95(1):114-118
5. Lapidus K, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, et al (2014) A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry. doi: 10.1016/j.biopsych.2014.03.026
6. McGirr A, Berlim MT, Bond DJ, Fleck MP, Yatham LN, Lam RW (2014) A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med:1-12
7. Sanacora G, Zarate CA, Krystal JH, Manji HK (2008) Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7(5):426-437
8. Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B et al (2011) The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res 191(2):122-127
9. Zarate C Jr, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G (2010) Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry 18(5):293-303
10. Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A et al (2012) Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71(11):939-946